These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24266760)

  • 1. Plasma stable, pH-sensitive non-ionic surfactant vesicles simultaneously enhance antiproliferative effect and selectivity of Sirolimus.
    Ghanbarzadeh S; Khorrami A; Pourmoazzen Z; Arami S
    Pharm Dev Technol; 2015 May; 20(3):279-87. PubMed ID: 24266760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Khorrami A
    Colloids Surf B Biointerfaces; 2014 Mar; 115():323-30. PubMed ID: 24394948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
    J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs.
    Tila D; Yazdani-Arazi SN; Ghanbarzadeh S; Arami S; Pourmoazzen Z
    EXCLI J; 2015; 14():21-32. PubMed ID: 26417350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.
    Ghanbarzadeh S; Khorrami A; Mohamed Khosroshahi L; Arami S
    Pharm Biol; 2014 Jul; 52(7):848-54. PubMed ID: 24920230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
    Wang M; Yuan Y; Gao Y; Ma HM; Xu HT; Zhang XN; Pan WS
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1134-41. PubMed ID: 22182601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
    Valizadeh H; Ghanbarzadeh S; Zakeri-Milani P
    Drug Dev Ind Pharm; 2015; 41(9):1558-65. PubMed ID: 25311425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs.
    Roux E; Francis M; Winnik FM; Leroux JC
    Int J Pharm; 2002 Aug; 242(1-2):25-36. PubMed ID: 12176222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusogenic activity of PEGylated pH-sensitive liposomes.
    Vanić Z; Barnert S; Süss R; Schubert R
    J Liposome Res; 2012 Jun; 22(2):148-57. PubMed ID: 22149717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood.
    Ishida T; Okada Y; Kobayashi T; Kiwada H
    Int J Pharm; 2006 Feb; 309(1-2):94-100. PubMed ID: 16364578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of pH-sensitive polymer/niosome complexes.
    Francis MF; Dhara G; Winnik FM; Leroux JC
    Biomacromolecules; 2001; 2(3):741-9. PubMed ID: 11710027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.
    Xu H; Deng Y; Chen D; Hong W; Lu Y; Dong X
    J Control Release; 2008 Sep; 130(3):238-45. PubMed ID: 18657874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
    Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K
    AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20.
    Di Marzio L; Marianecci C; Petrone M; Rinaldi F; Carafa M
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):18-24. PubMed ID: 20832262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery.
    Chen D; Yu H; Mu H; Li G; Shen Y
    Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):205-9. PubMed ID: 24823243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes.
    Kanamala M; Palmer BD; Wilson WR; Wu Z
    Int J Pharm; 2018 Sep; 548(1):288-296. PubMed ID: 29981407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
    Bendas ER; Abdullah H; El-Komy MH; Kassem MA
    Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.